openPR Logo
Press release

Asia-Pacific Contraceptive Drugs Market Report 2017

02-07-2018 02:35 PM CET | Health & Medicine

Press release from: Pharma & Healthcare Industry

The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.

In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/38050

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Contraceptive Drugs for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Contraceptive Drugs market competition by top manufacturers/players, with Contraceptive Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including :
Cipla,Bayer,Merck,Teva Pharmaceutical,Allergan,Pfizer,Reckitt Benckiser,Mankind Pharma,Janssen Pharmaceutical,HLL Lifecare,Mithra Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Contraceptive Drugs for each application, includin
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics

Get discount on this report : https://www.worldwidemarketreports.com/discount/38050

Table of Contents

Asia-Pacific Contraceptive Drugs Market Report 2017
1 Contraceptive Drugs Overview
1.1 Product Overview and Scope of Contraceptive Drugs
1.2 Classification of Contraceptive Drugs by Product Category
1.2.1 Asia-Pacific Contraceptive Drugs Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Contraceptive Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Oral Contraceptives
1.2.4 Contraceptive Injectable
1.2.5 Topical Contraceptive Patch
1.3 Asia-Pacific Contraceptive Drugs Market by Application/End Users
1.3.1 Asia-Pacific Contraceptive Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Independent Pharmacy
1.3.4 Online Platform
1.3.5 Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR :
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Contraceptive Drugs Market Report 2017 here

News-ID: 935653 • Views: 167

More Releases from Pharma & Healthcare Industry

Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity …
Worldwide Market Reports added Latest Research Report titled "Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026" to its Large Report database. Thalidomide is an immunomodulatory drug and a prototype of the thalidomide class of drugs. It is mainly used in the treatment of certain cancers (multiple myeloma) and of a complication of leprosy. It is sold under the brand name Immunoprin. It has many applications in the
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Rx Medical Food Trends Estimates High Demand by 2024
Medical food is a category of products for dietary management or supportive therapy for specific disease or medical conditions such as pulmonary and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status, which is assigned to naturally found food materials. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and
Specialty CRO's Market - Regional Insights
On the basis of geography, global specialty CROs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the market over the forecast period, owing to the fact that pharmaceutical and biotech companies in this region spends significant amount on research and development, in order to bring novel therapies to the market. Click To Continue Reading; https://www.coherentmarketinsights.com/ongoing-insight/specialty-cros-market-1627 As per the estimation

All 5 Releases


More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost